Other News To Note
Wednesday, February 20, 2013
Galectin Therapeutics Inc., of Norcross, Ga., said it established a drug discovery program in collaboration with Geert-Jan Boons' lab at the University of Georgia to discover new carbohydrate molecules that can be used in the therapy of diseases where galectin proteins play a major role, including cancer and inflammatory and fibrotic disorders.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.